Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Betnovate 0.1% lotion
1304000F0BBAIBC
|
Betnovate (Topical) | Betamethasone valerate | Skin | 713 |
|
Xemacort 20mg/g / 1mg/g cream
1304000F0BHAACC
|
Xemacort | Betamethasone valerate | Skin | 644 |
|
Betamethasone valerate 2.25mg medicated plasters
1304000F0AADWDW
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 458 |
|
Fucibet Lipid cream
1304000F0BCACCC
|
Fucibet | Betamethasone valerate | Skin | 380 |
|
Coal tar soln 5% in Betamethasone valerate 0.025% oint
1304000F0AAECEC
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 97 |
|
Betamethasone valerate 0.1% ointment 25% in Coal tar paste
1304000F0AACSCS
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 14 |
|
Betamethasone valerate 0.1% oint 10% in White soft paraffin
1304000F0AADBDB
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 4 |
|
Betamethasone valerate 0.1% oint 50% in Gen Unguentum M crm
1304000F0AAFSFS
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 4 |
|
Betnovate-C cream
1304000F0BBAKCA
|
Betnovate (Topical) | Betamethasone valerate | Skin | 4 |
|
Coal tar 5% in Betamethasone valerate 0.025% ointment
1304000F0AAEKEK
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 4 |
|
Betamethasone valerate 0.1% oint 50% in White soft paraffin
1304000F0AACZCZ
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Coal tar 10% in Betamethasone valerate 0.025% ointment
1304000F0AAETET
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Coal tar solution 5% in Betamethasone valerate 0.025% cream
1304000F0AAEPEP
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 3 |
|
Betamethasone valerate 0.1% cream 25% in Coal tar paste
1304000F0AAEQEQ
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 2 |
|
Betnovate-C ointment
1304000F0BBAMCD
|
Betnovate (Topical) | Betamethasone valerate | Skin | 2 |
|
Betamethasone valerate 0.1% cream 10% in Aqueous cream
1304000F0AACPCP
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1 |
|
Betamethasone valerate 0.1% oint 30% in White soft paraffin
1304000F0AADKDK
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 1 |
|
Betnovate-N cream
1304000F0BBALCB
|
Betnovate (Topical) | Betamethasone valerate | Skin | 1 |
|
Betameth val 0.1% crm 25% / Coal tar soln 5% in Unguen M crm
1304000F0AAFKFK
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betameth val 0.1% crm 25% /Coal tar soln 10% in Unguen M crm
1304000F0AAFLFL
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betameth val 0.1% oint 25%/Coal tar soln 5% in Unguen M crm
1304000F0AAFDFD
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betamethasone valerate 0.025% oint 10% in WSP
1304000F0AAEBEB
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betamethasone valerate 0.025% oint 50% in WSP
1304000F0AAEIEI
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betamethasone valerate 0.025% ointment 50% in Coal tar paste
1304000F0AAEGEG
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
|
Betamethasone valerate 0.1% 30% in Cetomacrogol (Formula A)
1304000F0AADPDP
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.